Fagron NV (EBR:FAGR)
Belgium · Delayed Price · Currency is EUR 20.75
+0.10 (0.48%)
Aug 7, 2025, 4:26 PM CET
Splunk Market Cap
Fagron NV has a market cap or net worth of €1.51 billion as of August 7, 2025. Its market cap has increased by 10.11% in one year.
Market Cap
1.51B
Enterprise Value
1.83B
Revenue
918.75M
Ranking
n/a
PE Ratio
17.65
Stock Price
$20.75
Market Cap Chart
Since October 15, 2007, Fagron NV's market cap has increased from 312.17M to 1.51B, an increase of 383.47%. That is a compound annual growth rate of 9.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 1.53B | 25.31% |
| Dec 31, 2024 | 1.22B | 0.73% |
| Dec 29, 2023 | 1.21B | 25.41% |
| Dec 30, 2022 | 967.24M | -10.30% |
| Dec 31, 2021 | 1.08B | -21.59% |
| Dec 31, 2020 | 1.38B | -1.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 35.96B |
| UCB SA | 35.08B |
| Financière de Tubize | 6.63B |
| Ion Beam Applications | 345.35M |
| Nyxoah | 241.46M |
| Hyloris Pharmaceuticals | 187.60M |
| Onward Medical | 185.95M |
| Sequana Medical NV | 81.71M |